Search

Your search keyword '"Bernstein, Jonine"' showing total 16 results
Start Over Author "Bernstein, Jonine" Publisher wiley
16 results on '"Bernstein, Jonine"'

1. Association of contralateral breast cancer risk with mammographic density defined at higher‐than‐conventional intensity thresholds

Author

Watt, Gordon P., primary, Knight, Julia A., additional, Nguyen, Tuong L., additional, Reiner, Anne S., additional, Malone, Kathleen E., additional, John, Esther M., additional, Lynch, Charles F., additional, Brooks, Jennifer D., additional, Woods, Meghan, additional, Liang, Xiaolin, additional, Bernstein, Leslie, additional, Pike, Malcolm C., additional, Hopper, John L., additional, and Bernstein, Jonine L., additional

Published
2022
Full Text
View/download PDF

3. Body mass index, weight change, and risk of second primary breast cancer in the <scp>WECARE</scp> study: influence of estrogen receptor status of the first breast cancer

Author

Brooks, Jennifer D., John, Esther M., Mellemkjær, Lene, Lynch, Charles F., Knight, Julia A., Malone, Kathleen E., Reiner, Anne S., Bernstein, Leslie, Liang, Xiaolin, Shore, Roy E., Stovall, Marilyn, Bernstein, Jonine L., Capanu, Marinela, Orlow, Irene, Robson, Mark, Woods, Meghan, Boice, John D., Brooks, Jennifer, Concannon, Patrick, Conti, Dave V., Duggan, David, Elena, Joanne W., Haile, Robert W., Olsen, Jørgen H., Seminara, Daniela, Stram, Daniel O., Tischkowitz, Marc, and Thomas, Duncan C.

Subjects
Adult, Risk, Cancer Research, medicine.medical_specialty, Population, Estrogen receptor, Breast Neoplasms, lcsh:RC254-282, Body Mass Index, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, medicine, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, education, Estrogen Receptor Status, Original Research, Aged, Neoplasm Staging, 2. Zero hunger, Gynecology, education.field_of_study, business.industry, Obstetrics, Body Weight, Weight change, Cancer, Neoplasms, Second Primary, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, 3. Good health, Receptors, Estrogen, Oncology, Case-Control Studies, Population Surveillance, 030220 oncology & carcinogenesis, contralateral breast cancer, Female, medicine.symptom, business, Cancer Prevention, Body mass index, Weight gain, estrogen receptor, SEER Program
Abstract

Studies examining the relationship between body mass index (BMI) and risk of contralateral breast cancer (CBC) have reported mixed findings. We previously showed that obese postmenopausal women with estrogen receptor (ER)‐negative breast cancer have a fivefold higher risk of CBC compared with normal weight women. In the current analysis, we reexamined this relationship in the expanded Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study, focusing on the impact of menopausal status and ER status of the first breast cancer. The WECARE Study is a population‐based case–control study of young women with CBC (cases, N = 1386) and with unilateral breast cancer (controls, N = 2045). Rate ratios (RR) and 95% confidence intervals (CI) were calculated to assess the relationship between BMI and risk of CBC stratified by menopausal and ER status. Positive associations with obesity and weight gain were limited to women who became postmenopausal following their first primary breast cancer. Among those with an ER‐negative first breast cancer, obesity (vs. normal weight) at first diagnosis was associated with an increased risk of CBC (RR = 1.9, 95% CI: 1.02, 3.4). Also, weight gain of ≥10 kg after first diagnosis was associated with an almost twofold increased risk of CBC (RR = 1.9, 95% CI: 0.99, 3.8). These results suggest that women with an ER‐negative first primary cancer who are obese at first primary diagnosis or who experience a large weight gain afterward may benefit from heightened surveillance. Future studies are needed to address the impact of weight loss interventions on risk of CBC.

Published
2016

4. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics

Author

Ostrom, Quinn T., primary, Egan, Kathleen M., additional, Nabors, L. Burt, additional, Gerke, Travis, additional, Thompson, Reid C., additional, Olson, Jeffrey J., additional, LaRocca, Renato, additional, Chowdhary, Sajeel, additional, Eckel‐Passow, Jeanette E., additional, Armstrong, Georgina, additional, Wiencke, John K., additional, Bernstein, Jonine L., additional, Claus, Elizabeth B., additional, Il'yasova, Dora, additional, Johansen, Christoffer, additional, Lachance, Daniel H., additional, Lai, Rose K., additional, Merrell, Ryan T., additional, Olson, Sara H., additional, Sadetzki, Siegal, additional, Schildkraut, Joellen M., additional, Shete, Sanjay, additional, Houlston, Richard S., additional, Jenkins, Robert B., additional, Wrensch, Margaret R., additional, Melin, Beatrice, additional, Amos, Christopher I., additional, Huse, Jason T., additional, Barnholtz‐Sloan, Jill S., additional, and Bondy, Melissa L., additional

Published
2019
Full Text
View/download PDF

6. Contralateral breast cancers: Independent cancers or metastases?

Author

Begg, Colin B., primary, Ostrovnaya, Irina, additional, Geyer, Felipe C., additional, Papanastasiou, Anastasios D., additional, Ng, Charlotte K.Y., additional, Sakr, Rita A., additional, Bernstein, Jonine L., additional, Burke, Kathleen A., additional, King, Tari A., additional, Piscuoglio, Salvatore, additional, Mauguen, Audrey, additional, Orlow, Irene, additional, Weigelt, Britta, additional, Seshan, Venkatraman E., additional, Morrow, Monica, additional, and Reis-Filho, Jorge S., additional

Published
2017
Full Text
View/download PDF

7. History of chickenpox in glioma risk: a report from the glioma international case–control study (GICC)

Author

Amirian, E. Susan, primary, Scheurer, Michael E., additional, Zhou, Renke, additional, Wrensch, Margaret R., additional, Armstrong, Georgina N., additional, Lachance, Daniel, additional, Olson, Sara H., additional, Lau, Ching C., additional, Claus, Elizabeth B., additional, Barnholtz‐Sloan, Jill S., additional, Il'yasova, Dora, additional, Schildkraut, Joellen, additional, Ali‐Osman, Francis, additional, Sadetzki, Siegal, additional, Jenkins, Robert B., additional, Bernstein, Jonine L., additional, Merrell, Ryan T., additional, Davis, Faith G., additional, Lai, Rose, additional, Shete, Sanjay, additional, Amos, Christopher I., additional, Melin, Beatrice S., additional, and Bondy, Melissa L., additional

Published
2016
Full Text
View/download PDF

11. Statistical Methods for Analysis of Radiation Effects with Tumor and Dose Location-Specific Information with Application to the WECARE Study of Asynchronous Contralateral Breast Cancer

Author

Langholz, Bryan, primary, Thomas, Duncan C., additional, Stovall, Marilyn, additional, Smith, Susan A., additional, Boice, John D., additional, Shore, Roy E., additional, Bernstein, Leslie, additional, Lynch, Charles F., additional, Zhang, Xinbo, additional, and Bernstein, Jonine L., additional

Published
2008
Full Text
View/download PDF

16. Agreement of medical record abstraction and self-report of breast cancer treatment with an extended recall window.

Author

Reiner AS, Knight JA, John EM, Lynch CF, Malone KE, Liang X, Woods M, Root JC, and Bernstein JL

Abstract

Background: Medical record abstraction (MRA) and self-report questionnaires are two methods frequently used to ascertain cancer treatment information. Prior studies have shown excellent agreement between MRA and self-report, but it is unknown how a recall window longer than 3 years may affect this agreement., Methods: The Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study is a multicenter, population-based case-control study of controls with unilateral breast cancer individually matched to cases with contralateral breast cancer. Participants who were diagnosed with a first primary breast cancer from 1985 to 2008 before the age of 55 years completed a questionnaire that included questions on treatment. First primary breast cancer treatment information was abstracted from the medical record from radiation oncology clinic notes for radiation treatment and from systemic adjuvant treatment reports for hormone therapy and chemotherapy. Agreement between MRA and self-reported treatment was assessed with the kappa statistic and corresponding 95% confidence intervals (CIs)., Results: A total of 2808 participants with MRA and self-reported chemotherapy treatment information, 2733 participants with MRA and self-reported hormone therapy information, and 2905 participants with MRA and self-reported radiation treatment information were identified. The median recall window was 12.5 years (range, 2.8-22.2 years). MRA and self-reported treatment agreement was excellent across treatment modalities (kappa chemo , 98.5; 95% CI, 97.9-99.2; kappa horm , 87.7; 95% CI, 85.9-89.5; kappa rad , 97.9; 95% CI, 97.0-98.7). There was no heterogeneity across recall windows (p chemo  = .46; p horm  = .40; p rad  = .61)., Conclusions: Agreement between self-reported and MRA primary breast cancer treatment modality information was excellent for young women diagnosed with breast cancer and was maintained even among women whose recall window was more than 20 years after diagnosis., (© 2024 American Cancer Society.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results